News

Featured News
Canadians living with type 1 diabetes will have improved access to the treatments and devices they need through a new national pharmacare program 
February 29, 2024 – Ottawa – Today marks a historic moment for the type 1 diabetes (T1D) community in Canada. JDRF Canada is thrilled to have been part of the […]
Read More

The JDRF House ParT1D for a Cure presented by Omnipod raises $2.1 million dollars to accelerate research

TORONTO, ON — June 15, 2020 – This past Sunday June 14th, the type 1 diabetes (T1D) community took part in the JDRF House ParT1D for a Cure presented by Omnipod – Canada’s largest virtual house turning type one diabetes into type none. Despite the reality of physical distancing, this new, family-friendly virtual event united Canadians from coast to coast to get loud and raise critical funds for JDRF and its vital T1D research program.

The JDRF House ParT1D for a Cure presented by Omnipod

TORONTO, ON — June 11, 2020 – On June 14th, the type 1 diabetes (T1D) community will take part in the JDRF House ParT1D for a Cure presented by Omnipod – Canada’s largest virtual house turning type one diabetes into type none. Despite the reality of physical distancing, this new, family-friendly virtual event will unite Canadians from coast to coast to get loud and raise critical funds for JDRF and its vital T1D research program.

JDRF welcomes announcement from the Government of Canada to better support Canadians with disabilities during COVID-19, including those living with type 1 diabetes

Toronto, ON, June 5, 2020 – JDRF welcomes today’s announcement from the Government of Canada to better support Canadians with disabilities during COVID-19, including those living with type 1 diabetes (T1D). While more details around the program are yet to be released, we do know that a one-time, tax-free payment will be made to all Canadians who currently qualify for the disability tax credit (DTC).

New UK studies examine risks of COVID-19 in people with type 1 diabetes

The National Health Service (NHS) in England recently released two studies that provide the first information available about risks of COVID-19 in people with type 1 diabetes (T1D). The findings – which are still undergoing peer review – tell us that for people that need to be hospitalized due to COVID-19, those with type 1 diabetes are at higher risk of death than people with type 2 diabetes, or the general population.

JDRF Launches Canada’s Largest Virtual House Party to Raise Funds for Diabetes

Toronto, Ontario, April 20, 2020 – In the new reality of physical distancing, JDRF is bringing Canadians together to unite, get loud and raise funds to accelerate the pace of type 1 diabetes research – all from home. The JDRF House ParT1D for a Cure, presented by Omnipod, will take place on Sunday, June 14, 2020, and is Canada’s largest virtual house party turning type one diabetes into type none.

JDRF Canada responds to INESS recommendations regarding Dexcom G6 Continuous Glucose Monitor

Toronto, Ontario – February 27, 2020 – JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, is hopeful that the Government of Quebec might still consider provincial coverage for Continuous Glucose Monitoring (CGM) in spite of a report released this month by the Institut national d’excellence en santé et services sociaux (INESS).